Author(s): Glenn J. Hanna, MD1,Harita Dharanesswaran, BS2,Anita Giobbie-Hurder, MS3,John J. Harran, RN2,Zixi Liao, RN2,Lori Pai, MD4,Vatche Tchekmedyian, MD5,Emily S. Ruiz, MD2,Abigail H. Waldman, MD2,Chrysalyne D. Schmults, MD2,Leonardo V. Riella, MD, PhD6,Patrick Lizotte, PhD7,Cloud P. Paweletz, PhD7,Anil K. Chandraker, MD, MBCHB8,Naoka Murakami, MD, PhD9,Ann W. Silk, MD10
Author Affiliations
1Center for Head and Neck Oncology, Dana-Farber Cancer Institute, Boston, MA, 2Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, 3Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, 4Department of Hematology/Oncology, Tufts Medical Center, Boston, MA, 5Department of Hematology/Oncology, Maine Health Cancer Center, Portland, ME, 6Department of Medicine, Renal Division, Massachusetts General Hospital, Boston, MA, 7Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, 8Division of Renal Medicine, Brigham and Women’s Hospital, Boston, MA, 9Division of Renal Medicine, Brigham and Women’s Hospital, Boston, MA, 10Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA